Author details

Full Name

Carmen de Torres

Affiliation

ORCID

Career Start Year

1997

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35101866	Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma.	Cancer Research	2022
36131014	Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
36446943	Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.	Nature	2022
33741928	The transcriptional landscape of Shh medulloblastoma.	Nat Commun	2021
31876779	WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.	J Pediatr Hematol Oncol	2021
31784426	Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.	Cancer Research	2020
31293052	Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression.	Mol Oncol	2019
29542868	Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.	Cancer Med	2018
29967352	Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.	Nat Med	2018
30132831	Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.	Int J Cancer	2018
29897054	Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.	Front Oncol	2018
29351917	A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.	Clin Cancer Res	2018
29755954	Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.	Front Oncol	2018
29438908	In situ monitoring of PTHLH secretion in neuroblastoma cells cultured onto nanoporous membranes.	Biosensors and Bioelectronics	2018
29592813	Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.	Genome Med	2018
28233413	Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression.	Pediatr Blood Cancer	2017
28727518	Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.	J Clin Oncol	2017
28412222	Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8.	J Control Release	2017
28787430	GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).	Br J Cancer	2017
28966033	Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.	Cancer Cell	2017
28924151	DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders.	Sci Rep	2017
29163787	Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.	Oncotarget	2017
27862333	Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors.	Mol Carcinog	2017
28263309	EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.	Nat Med	2017
28251325	Second re-irradiation for DIPG progression, re-considering "old strategies" with new approaches.	Childs Nerv Syst	2017
26492976	Detection of parathyroid hormone-like hormone in cancer cell cultures by gold nanoparticle-based lateral flow immunoassays.	Nanomedicine: Nanotechnology, Biology, and Medicine	2016
26893368	Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.	Oncotarget	2016
27242543	Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System.	Frontiers in Physiology	2016
27009842	Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.	Oncotarget	2016
27319373	Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.	Cancer Lett	2016
27317769	RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-ÎºB pathway, independently of the fusion oncoprotein.	Oncotarget	2016
27213811	Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.	PLoS One	2016
25103338	Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker.	Biosensors and Bioelectronics	2015
25596034	Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).	Clin Transl Oncol	2015
26067621	DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights.	Epigenomics	2015
24705252	Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.	Nat Genet	2014
25512523	Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.	Proc Natl Acad Sci U S A	2014
24493713	Cytogenetic prognostication within medulloblastoma subgroups.	J Clin Oncol	2014
24868582	Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study.	Acta Ophthalmol	2014
25186949	The genomic landscape of pediatric Ewing sarcoma.	Cancer Discov	2014
23407937	LMO4 is an essential cofactor in the Snail2-mediated epithelial-to-mesenchymal transition of neuroblastoma and neural crest cells.	Journal of Neuroscience	2013
23951165	EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1.	PLoS One	2013
23533647	Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.	PLoS One	2013
23108190	The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.	Carcinogenesis	2013
21994054	Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome.	Pediatr Blood Cancer	2012
22328561	A three-gene expression signature model for risk stratification of patients with neuroblastoma.	Clin Cancer Res	2012
23144874	DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.	PLoS One	2012
21903323	Identification of tumoral glial precursor cells in neuroblastoma.	Cancer Lett	2011
21384537	Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.	Pediatr Blood Cancer	2011
20103160	Effect of freeze-drying and oven-drying on volatiles and phenolics composition of grape skin.	Analytica Chimica Acta	2010